Anticoagulant therapy: we have to do better! A systematic review

被引:0
|
作者
Wiltink, Ed H. [1 ]
机构
[1] St Antonius Hosp, Dept Clin Pharm & Pharmacol, NL-3430 EM Nieuwegein, Netherlands
关键词
ADVERSE DRUG EVENTS; HOSPITAL ADMISSIONS; ATRIAL-FIBRILLATION; WARFARIN; ERRORS; PREVENTION; STROKE; RISK;
D O I
10.1136/ejhpharm-2013-000295
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim Anticoagulant therapy is considered a high-risk medication strategy with a narrow therapeutic window and the need for close monitoring, particularly with vitamin K antagonists. The nature of the drugs as well as the way they are administered make it more likely mistakes will occur. At all stages of care, ambulatory as well as in hospital, avoidable medication errors are seen. This review was performed to elucidate the number and nature of medication errors with anticoagulants and to look at possibilities for improving anticoagulant therapy. Methods A literature review was performed in PubMed, Medline and other sources looking after articles concerning medication errors in which anticoagulants are separately mentioned. From these articles, the risk factors were identified. Results A total of 17 papers were selected where medication errors with anticoagulant drugs were described. It became clear that medication errors occur from the doctor prescribing the medication, to the compliance of the patient with taking the treatment, and all steps in between. Communication between caregivers and between caregivers and patients seems to be an important factor. Conclusions This review shows that improvement is possible throughout the whole anticoagulant medication chain, starting with instructions for those prescribing drugs to education for patients.
引用
收藏
页码:108 / 112
页数:5
相关论文
共 50 条
  • [31] Can we do better at measuring patient-reported outcomes after cranioplasty? A systematic review
    Zaramo, Taborah Z.
    Zelko, Ian
    Ragland, Dashaun
    Tunyi, Jude
    Kaur, Manraj N.
    Bajestani, Nojan
    Lee, Clara N.
    Chung, Kevin C.
    Mitchell, Kerry-Ann S.
    NEUROSURGICAL REVIEW, 2023, 46 (01)
  • [32] Can we do better at measuring patient-reported outcomes after cranioplasty? A systematic review
    Taborah Z. Zaramo
    Ian Zelko
    Dashaun Ragland
    Jude Tunyi
    Manraj N. Kaur
    Nojan Bajestani
    Clara N. Lee
    Kevin C. Chung
    Kerry-Ann S. Mitchell
    Neurosurgical Review, 46
  • [33] We should do better in accounting for multiple births in neonatal randomised trials: a methodological systematic review
    Robledo, Kristy P.
    Libesman, Sol
    Yelland, Lisa Nicole
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2024,
  • [34] Mapping extent of floods: What we have learned and how we can do better
    Wang, Yong
    Natural Hazards Review, 2002, 3 (02) : 68 - 73
  • [35] Adherence to dual antiplatelet therapy: can we do better?
    Yallapragada, Srinivas
    Siddiqui, Saifullah
    Gindi, Ryan
    Shroff, Adhir
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (10) : 1417 - 1424
  • [36] Therapy for giant cell arteritis: Can we do better?
    Spiera, Robert F.
    Spiera, Harry
    ARTHRITIS AND RHEUMATISM, 2006, 54 (10): : 3071 - 3074
  • [37] We Can Do Better: Aging and the Value of Physical Therapy
    Avers, Dale
    JOURNAL OF GERIATRIC PHYSICAL THERAPY, 2020, 43 (03) : E31 - E44
  • [38] Adjuvant Therapy of Breast Cancer: Can We Do Better?
    Thomssen, Christoph
    Janni, Wolfgang
    BREAST CARE, 2009, 4 (05) : 292 - 293
  • [39] Do we have to rethink inclusive pedagogies for secondary schools? A critical systematic review of the international literature
    Koutsouris, George
    Bremner, Nicholas
    Stentiford, Lauren
    BRITISH EDUCATIONAL RESEARCH JOURNAL, 2024, 50 (01) : 260 - 286
  • [40] Surgery for Adrenocortical Carcinoma: Do We Have Enough Evidence to Perform Robotic Approach? A Systematic Review
    Fassari, Alessia
    Petramala, Luigi
    Letizia, Claudio
    Cavallaro, Giuseppe
    INDIAN JOURNAL OF SURGERY, 2024, 86 (04) : 689 - 695